COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations

NCT04761822 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

746

Enrollment

NIH

Sponsor class

Conditions

SARS-CoV Infection
COVID-19
Allergic Reaction
Mast Cell Disorder

Interventions

BIOLOGICAL: Moderna COVID-19 Vaccine
BIOLOGICAL: Pfizer-BioNTech COVID-19 Vaccine
BIOLOGICAL: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]